Development and Use of Adverse Outcome Pathways that Predict Adverse Developmental Neurotoxicity

Request for Applications closing date: December 19, 2012

View RFA Text


Currently displaying 4 records per page. Change result display: [ 10 25 50 ALL ]
# Add/
Remove
Selection
Identifier Abstract Principal Investigator Annual/ Final Reports Pubs Count Institution Project Period
<< STAR GRANTS AND STAR CENTERS >>
1 R835550
Grant
Identification and Scientific Validation of AOPS Involving Genomic and Nongenomic Intracellular Thyroid Hormone Signaling in Neurodevelopment Lein, Pamela J
Fritsche, Ellen  
2014

2015

Final

Total Pubs: 17
Journals: 3
-- No Books --
 
University of California - Davis, Leibniz Research Institute for Environmental Medicine October 2013 -
September 2016  
2 R835552
Grant
Human Stem Cell-Based Platform to Predict Selective Developmental Neurotoxicity Terskikh, Alexey V.
Farhy, Chen  
2014

2015

2016

  Sanford-Burnham Medical Research Institute September 2013 -
August 2017  
3 R835551
Grant
Human Neural Stem Cell Metabolomic, Cellular and Organ Level Adverse Outcome Pathway Relationships for Endocrine Active Compounds Stice, Steve
Lu, Kun
Smith, Mary Alice
Zhao, Qun  
2014

2015

2016

Total Pubs: 28
Journals: 3
-- No Books --
 
University of Georgia September 2013 -
August 2016
(Extended to August 2017)  
4 R835541
Grant
Establishing an AOP for the Role of the Vitamin D Receptor in Developmental Neurotoxicity Kullman, Seth W.
Levin, Edward D
Slotkin, Theodore  
2014

2015

2017

Total Pubs: 9
Journals: 1
-- No Books --
 
Duke University Medical Center, North Carolina State University July 2013 -
June 2016
(Extended to January 2018)  
Currently displaying 4 records per page. Change result display: [ 10 25 50 ALL ]



Results Per Page:

Select the fields to be returned in table